Meyka AI API is live for developers.Start building.
Advertisement
The Valens Company Inc.

The Valens Company Inc. (VLNS) Stock Overview

Explore The Valens Company Inc.’s financial performance, market position, analyst ratings, and future outlook.

VLNSNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.76
$0.00(0.00%)
U.S. Market opens in 47h 37m
Advertisement

The Valens Company Inc. (VLNS)

Meyka AI Score

Z

Key Financials

Market Cap61.5M
P/E RatioN/A
EPS (TTM)$-0.74
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

VLNS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of The Valens Company Inc. (VLNS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 61.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-1.65%
3-Year Change
-1.65%
5-Year Change
-1.65%
All-Time (Max) Change
-1.65%

Contact Information

NaN
96 Spadina Avenue, Toronto, ON, M5V 2J6

Company Facts

4,450 Employees
IPO DateSep 28, 2009
CountryCA

Frequently Asked Questions